PP
NVCR icon

PDT Partners’s NovoCure NVCR Stock Holding History

PDT Partners’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$243K Hold
22,252
– – 0.01% 478
2025
Q4 		$288K Buy
+22,252
New +$286K 0.02% 483
2025
Q3 		– Sell
-21,558
Closed -$384K – 684
2025
Q2 		$384K Buy
+21,558
New +$376K 0.02% 558
2025
Q1 		– Sell
-80,232
Closed -$2.39M – 823
2024
Q4 		$2.39M Sell
80,232
-31,851
-28% -$674K 0.21% 165
2024
Q3 		$1.75M Sell
112,083
-76,339
-41% -$1.38M 0.16% 239
2024
Q2 		$3.23M Buy
188,422
+100
+0.1% +$1.76K 0.31% 96
2024
Q1 		$2.94M Buy
188,322
+163,550
+660% +$2.41M 0.28% 114
2023
Q4 		$370K Buy
+24,772
New +$332K 0.04% 442
2020
Q3 		– Sell
-14,430
Closed -$856K – 817
2020
Q2 		$856K Buy
+14,430
New +$949K 0.06% 307

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

PDT Partners's NVCR Position: Q1 2026 in Review

PDT Partners held its NovoCure (NVCR) position steady in Q1 2026 at 22,252 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #478.

PDT Partners first reported a position in NVCR in Q2 2020 and has held it in 9 quarters since. The position peaked at $3.23M in Q2 2024. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • PDT Partners held 22,252 shares of NovoCure worth $243K as of Q1 2026.
  • PDT Partners left its NovoCure share count unchanged in Q1 2026.
  • NovoCure made up 0.01% of PDT Partners's portfolio in Q1 2026, its #478 holding.
  • PDT Partners first reported a position in NovoCure in Q2 2020 and has held it in 9 quarters since.
  • PDT Partners's NovoCure position peaked at $3.23M in Q2 2024.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.